Matthew R. Kane, President and CEO at PRECISION BIOSCIENCES INC (DTIL), sold 19,410 shares at $12.23 ($237K) on 2021-02-18, disclosed to the SEC on 2021-02-22.
Open-market sale of $237k DTIL by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.23 | 9,705 | $119K | 50.0% |
| 2 | $12.23 | 9,705 | $119K | 50.0% |
| Total | $12.23 avg | 19,410 | $237K | 100% |
| Filing → |
| DTIL | SELL | 2021-04-14 | $169K | — | Filing → |
| DTIL | SELL | 2021-04-12 | $260K | — | Filing → |
| DTIL | SELL | 2021-03-16 | $221K | — | Filing → |